I now have comprehensive, detailed content from multiple authoritative sources. Let me compile thorough MBBS-level contraceptive counselling notes.
Contraceptive Counselling - MBBS Notes
1. Introduction & Aims of Counselling
Contraceptive counselling aims to:
- Prevent unintended pregnancy (globally ~49% of all pregnancies are unintended)
- Reduce abortion rates
- Match the patient with a method that maximises compliance and minimises side effects
- Provide STI protection advice alongside pregnancy prevention
- Respect patient autonomy and individual circumstances
The counselling decision-making process relies on understanding:
- Efficacy of each method (typical vs. perfect use)
- Side effect profile of estrogen and progestin components
- Patient-specific factors (age, parity, medical comorbidities, breastfeeding status, future fertility plans)
Among women 15-44 years, the most common methods used are: OCPs (27.5%) > Female sterilisation (26.6%) > Male condom (16%) > Male sterilisation (10%) > IUDs and withdrawal (~5% each). - Textbook of Family Medicine 9e
2. Pre-Counselling Assessment
Before selecting any method, assess:
| Assessment Area | Key Points |
|---|
| Medical history | Blood pressure, lipid levels, liver and renal function, BMI |
| Reproductive history | Parity, menstrual pattern (cycle length, dysmenorrhoea, flow), future fertility intentions |
| Current bleeding pattern | Breakthrough bleeding? Amenorrhoea? |
| Pregnancy status | Exclude pregnancy before starting |
| Medications | Drug interactions (rifampicin, anticonvulsants, etc.) |
| STI risk | Number of partners, prior STIs |
| Breastfeeding status | Determines hormonal method eligibility |
| Special populations | Adolescents, perimenopausal, medical conditions (diabetes, epilepsy, cardiac disease) |
Obese women generally require higher doses of estrogen and progestin to achieve contraception without bleeding side effects. - Textbook of Family Medicine 9e
3. Efficacy of Contraceptive Methods
Pearl Index & Typical Use Failure Rates
| Method | Typical Use Failure (per 100 women/year) |
|---|
| No method | 85 |
| Fertility awareness methods | ~24 |
| Spermicide alone | ~28 |
| Male condom | ~18 |
| Female condom | ~21 |
| Diaphragm + spermicide | ~12 |
| Combined OCP | ~9 |
| Progestin-only pill | ~9 |
| Patch / Ring | ~9 |
| DMPA injection | ~6 |
| Copper IUD (Cu-T380A) | <1 |
| LNG-IUD (Mirena) | <1 |
| Subdermal implant | <1 |
| Vasectomy | <1 |
| BTL (female sterilisation) | 0.5 (2-10/1000 failure rate) |
| LAM (if all 3 criteria met) | <2 |
Key principle: Long-acting reversible contraceptives (LARCs) - IUDs and implants - are the most effective reversible methods and the most cost-effective over 5 years. - Berek & Novak's Gynecology; Textbook of Family Medicine 9e
4. Categories of Contraceptive Methods
4A. Combined Hormonal Contraceptives (CHC)
Include: Combined oral contraceptive pill (COCP), transdermal patch, vaginal ring (NuvaRing)
Mechanism:
- Primary: Inhibit ovulation via suppression of the HPO axis (LH surge suppression)
- Secondary: Thicken cervical mucus (progestin), thin endometrium (progestin)
Starting guidance:
- Can start any day of cycle (Quick Start); if not within first 5 days of menses, use backup method for 7 days
- A 3-month trial is needed to assess response to any new hormonal regimen
Absolute Contraindications (WHO MEC Category 4):
- Pregnancy
- Breastfeeding <6 weeks postpartum
- Age >35 years + smoking ≥15 cigarettes/day
- History of VTE or current DVT/PE
- Ischaemic heart disease or stroke
- Migraine with aura (any age)
- Active viral hepatitis, liver cirrhosis, hepatocellular adenoma/carcinoma
- Uncontrolled hypertension (>160/100 mmHg)
- Diabetes with vascular complications
- Breast cancer (current or within past 5 years)
Side Effects by Hormonal Component
Estrogen Excess:
- Bloating, fluid retention, cyclic weight gain, irritability
- DVT, pulmonary embolism, CVA, thromboembolic disease
- Nausea and vomiting
- Hypermenorrhoea, dysmenorrhoea, uterine fibroid growth
- Breast tenderness, cystic breast changes
- Chloasma (skin pigmentation)
- Cyclic headaches/migraine, visual changes
Estrogen Deficiency:
- Breakthrough bleeding early in cycle (days 1-9) or continuous spotting
- Atrophic vaginitis, absence of withdrawal bleeding
- Vasomotor symptoms
Progestin Excess:
- Weight gain, depression, fatigue
- Elevated blood pressure
- Decreased libido
- Oily skin, acne (androgenic progestins)
- Late cycle breakthrough bleeding (days 10-21)
Progestin Deficiency:
- Breakthrough bleeding later in cycle
- Dysmenorrhoea
Key counselling point: Most side effects from COCs can be managed by adjusting estrogen-to-progestin ratios rather than stopping the method entirely. - Textbook of Family Medicine 9e
Managing Common OCP Side Effects
| Problem | Likely Cause | Action |
|---|
| Breakthrough bleeding early in cycle (days 1-9) | Estrogen deficiency | Switch to pill with more estrogen, same progestin |
| Breakthrough bleeding late cycle (days 10-21) | Progestin deficiency | Switch to pill with more progestin, same estrogen |
| Continuous spotting throughout cycle | Estrogen deficiency | Increase estrogen without changing progestin |
| Heavy periods + bloating | Estrogen excess | Decrease estrogen dose |
| Elevated BP + depressed mood | Progestin excess | Switch to pill with less progestin |
| Acne + oily skin | Androgenic progestin | Switch to less androgenic progestin (e.g., norgestimate, desogestrel) |
| Nausea | Estrogen excess | Take pill at night with food; reduce estrogen dose |
4B. Progestin-Only Contraceptives
Include: Progestin-only pill (POP / mini-pill), DMPA injection (Depo-Provera), Subdermal implant (Nexplanon/Implanon)
Mechanism:
- Thicken cervical mucus (primary in POP)
- Inhibit ovulation (more consistent with DMPA and implant)
- Thin endometrium
Key Feature: Creates an estrogen deficiency state - leading to irregular bleeding or amenorrhoea. This is NOT harmful but must be counselled in advance.
Advantages:
- Safe in breastfeeding mothers (do not affect milk quality or quantity)
- Used when estrogen is contraindicated
- Can be used in postpartum period
Progestin-Only Pill (Mini-Pill)
- Must be taken at the same time each day (within 3-hour window)
- If >3 hours late: use backup contraception for 48 hours
- Suitable for breastfeeding women, older women (>35), smokers, women with migraines
DMPA (Depo-Provera) Injection
- 150 mg IM every 13 weeks (or SC every 12-14 weeks)
- Efficacy: 6 pregnancies per 100 women/year (typical use)
- Side effects: Menstrual irregularity (common; usually resolves), headaches, abdominal pain, average weight gain <2 kg/year
- Delayed return to fertility: 9-18 months after stopping - must counsel patients
- FDA black box warning (2004): Should not be used >2 consecutive years due to decreased bone mineral density (BMD); however, BMD substantially returns after discontinuation - this risk must be weighed against need for contraception
- Adequate calcium and vitamin D intake should be encouraged
Subdermal Implant (Nexplanon)
- Single rod inserted in upper arm; lasts 3 years
- Most effective reversible method (pregnancy <1%)
- 24% discontinuation at 2 years (lowest of all hormonal methods)
- Side effects: Irregular bleeding (common reason for discontinuation)
4C. Intrauterine Devices (IUDs)
Among the most effective forms of birth control: <1 pregnancy per 100 women/year
| Feature | Copper IUD (Cu-T380A / Paragard) | LNG-IUD (Mirena/Kyleena/Liletta) |
|---|
| Hormone | None | Levonorgestrel (progestin) |
| Duration | 10 years (+ potentially 1-2 more years) | 3-5 years depending on type |
| Mechanism | Copper is spermicidal; prevents fertilisation | Thickens cervical mucus + thins endometrium |
| Effect on periods | Heavier menses and cramping | Decreased or absent periods over time |
| Emergency use | Most effective emergency contraception | Not used for emergency contraception |
| Breastfeeding | Excellent option | Minor theoretical concerns with immediate postpartum; likely safe |
Side effects: Changes in bleeding patterns are common in first months. First-line treatment for bleeding/spotting: NSAIDs.
Adolescents: ACOG recommends LARC (IUD or implant) as the most cost-effective contraceptive for adolescents; risk of infertility (seen with older IUDs) is vastly reduced with modern monofilament-tail IUDs.
4D. Barrier Methods
| Method | Notes |
|---|
| Male condom | 18% typical use failure; most widely used barrier; ONLY method protecting against STIs |
| Female condom | 21% typical use failure |
| Diaphragm | Used with spermicide; requires correct fitting; fit only after uterine involution (6-8 weeks postpartum) |
| Cervical cap / Sponge | Lower efficacy in parous women |
| Spermicide alone | ~28% failure rate; no longer recommended alone due to facilitating HPV and HIV transmission (nonoxynol-9) |
"Considering all contraceptive options except abstinence, male and female condoms offer the most protection against sexually transmitted infections." - Textbook of Family Medicine 9e
If a lubricant is desired: saline-based lubricants are safest (oil-based lubricants degrade latex condoms).
4E. Fertility Awareness-Based Methods (FABM / Natural Family Planning)
- Highest failure rate of all purposeful methods (~24% typical use)
- Include: Calendar/rhythm method, Basal Body Temperature (BBT) method, Cervical mucus (Billings) method, Symptothermal method, Standard Days Method, TwoDay Method
- Standard Days Method and TwoDay Method are easiest to use and therefore more effective in practice
- Patient must abstain or use barrier methods on fertile days
- No exogenous hormones or devices - often chosen for religious or personal reasons
4F. Permanent Sterilisation
| Procedure | Details |
|---|
| Bilateral tubal ligation (BTL) | Female sterilisation; 2-10 per 1000 failure rate |
| Vasectomy | Male sterilisation; 11 per 1000 failure rate; outpatient; lower complication risk than BTL |
Key counselling points:
- Should only be offered to patients who truly desire permanent contraception
- Reversal is difficult, expensive, and associated with complications (including ectopic pregnancy)
- Vasectomy is NOT associated with prostate cancer, cardiovascular disease, or sexual dysfunction
4G. Emergency Contraception (EC)
| Method | Dose | Window | Notes |
|---|
| Progestin-only (Plan B / Levonelle) | 1.5 mg LNG single dose, or 0.75 mg x2, 12h apart | Up to 72 hours (up to 120 h less effective) | Fewer side effects, more effective than Yuzpe |
| Yuzpe method (combined) | 100 mcg EE + 0.5 mg LNG x2, 12h apart | Within 72 hours | More nausea and vomiting |
| Ulipristal acetate (ellaOne/Ella) | 30 mg single dose | Up to 120 hours | Progesterone receptor modulator |
| Copper IUD | Insert within 5 days | Up to 120 hours | Most effective EC (<0.1% failure); also provides ongoing contraception |
Mechanism of EC: Inhibit or delay ovulation. EC does NOT disrupt established implantation - it is NOT an abortifacient.
ACOG recommendation: An advance prescription for EC should be provided where needed to eliminate access barriers. All sexually active women should be counselled about EC.
5. Contraception in Special Populations
Adolescents
- Highest rate of unintended pregnancy AND highest discontinuation rate with any method
- 24-month discontinuation rates: IUD 23% | Implant 31% | OCP 57% | Patch 60% | Ring 59% | DMPA 62%
- ACOG recommends LARCs (IUD or implant) as the most cost-effective choice for adolescents
- Estrogen and progestin doses may need adjustment through adolescent to perimenopausal years
Perimenopausal Women
- Use of hormonal contraceptives (except OCP in women >40) has significantly reduced death risk from hormone-related side effects
- OCPs (regardless of tobacco use) carry higher death risk in women >40 years
Women with Medical Conditions
| Condition | Guidance |
|---|
| Hypertension (uncontrolled >160/100) | Avoid combined hormonal methods (WHO MEC 4) |
| Migraine with aura | Avoid estrogen-containing methods at any age |
| Diabetes with vascular disease | Avoid combined methods; use progestin-only or LARC |
| VTE/DVT history | Avoid all estrogen-containing methods |
| Liver disease | Avoid hormonal contraceptives |
| Epilepsy (on enzyme-inducing drugs) | Enzyme-inducing AEDs reduce OCP efficacy; higher dose or alternative method needed |
| Breastfeeding <6 weeks | Avoid estrogen; use progestin-only or non-hormonal methods |
| Obesity | May need higher-dose estrogen/progestin formulations |
| PCOS | OCPs are therapeutic (control androgenic symptoms and cycle) |
6. WHO Medical Eligibility Criteria (MEC) Categories
| Category | Meaning |
|---|
| 1 | No restriction - method can be used |
| 2 | Advantages generally outweigh risks |
| 3 | Risks generally outweigh advantages - use only if no alternatives |
| 4 | Unacceptable health risk - method should NOT be used |
7. Counselling Framework (GATHER Model)
Used in structured family planning counselling:
- G - Greet the client respectfully
- A - Ask about needs, concerns, current method, medical history
- T - Tell about available options (efficacy, advantages, side effects)
- H - Help the client choose a suitable method
- E - Explain how to use the chosen method correctly
- R - Return/follow-up - arrange review at 3 months; address any concerns
8. Counselling Points for Key Methods
| Method | What to Tell the Patient |
|---|
| COCP | Take daily at the same time; 3 months to judge tolerance; what to do if a pill is missed; common side effects; not protective against STIs |
| DMPA | Return to fertility delayed 9-18 months; menstrual irregularity expected; calcium/Vitamin D supplement; bone density concerns with prolonged use |
| Implant | Lasts 3 years; irregular bleeding is common; removed anytime; rapid return of fertility after removal |
| Copper IUD | Periods may be heavier and more painful; lasts 10 years; most effective EC option; no hormones |
| LNG-IUD | Periods will likely decrease or stop; not an abortifacient; lasts 3-5 years |
| Condom | Use correctly every time; only method preventing STIs; oil-based lubricants degrade latex |
| Sterilisation | Permanent intent required; reversal not guaranteed; post-vasectomy: use another method for first 3 months |
| FAB methods | Highest failure rate; requires motivation and consistent tracking; first ovulation precedes first menses |
9. Key Summary Points for MBBS Exams
- LARCs (IUDs + implants) are the most effective reversible contraceptives and most cost-effective over 5 years
- Copper IUD is the most effective emergency contraceptive
- Only condoms protect against STIs
- Progestin-only methods are preferred in breastfeeding women
- Combined hormonal methods are contraindicated in: migraine with aura, VTE history, age >35 + heavy smoking, <6 weeks postpartum breastfeeding
- DMPA causes delayed return of fertility (9-18 months) - must counsel patients planning future pregnancy
- EC is NOT an abortifacient - it prevents fertilisation/implantation; it does not terminate an established pregnancy
- Fertility awareness methods have the highest typical-use failure rates
- Spermicide (nonoxynol-9) alone is no longer recommended - it increases susceptibility to HPV and HIV
- ICD-10 code Z30.0 = Encounter for general counselling and advice on contraception
Sources:
- Textbook of Family Medicine 9e - Harper, Wilfing, Blanner (Chapter 26: Contraception)
- Berek & Novak's Gynecology
- Creasy & Resnik's Maternal-Fetal Medicine
- The Harriet Lane Handbook, 23rd edition
- Swanson's Family Medicine Review